Account Login
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Abiomed Inc (NQ: ABMD)
141.40 USD  -1.88 (-1.31%)
Official Closing Price  /  Updated: 5:10 PM EDT, Apr 3, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 440,792
Open 142.38
Bid (Size) 128.88 (1)
Ask (Size) 147.09 (1)
Prev. Close 143.28
Today's Range 140.82 - 145.70
52wk Range 119.01 - 288.47
Shares Outstanding 44,477,837
Dividend Yield N/A
Performance
YTD
-16.24%
-16.24%
1 Month
-5.22%
-5.22%
3 Month
-16.24%
-16.24%
6 Month
-15.34%
-15.34%
1 Year
-50.38%
-50.38%
Top News
More News
Abiomed’s Response to the COVID-19 Pandemic
Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, is taking a number of steps to aid the global medical community and contribute to improved patient care during the COVID-19 outbreak. Impella... Read More
from Business Wire News Releases
First Week of ABMD May 15th Options Trading
Investors in ABIOMED, Inc. (ABMD) saw new options begin trading this week, for the May 15th expiration.. Read More
category Stocks
from Market News Video
More News
Read More
10 Stocks To Buy With Low Debt And High Liquidity
category Education , GOOG , Benzinga , and 16 more.
from Benzinga
Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Death and Complications in Patients who Receive PVADs (Impella)
from Business Wire News Releases
Live Nation Entertainment Now #406 Largest Company, Surpassing ABIOMED
category Stocks
from Market News Video
9.8% Return Seen to Date on SmarTrend Abiomed Inc Call (ABMD)
from Comtex SmarTrend® News Briefs
Look Under The Hood: IVE Has 16% Upside
category ETFs
from ETF Channel
Watch for Continued Losses in Shares of Abiomed Inc (ABMD)
from Comtex SmarTrend® News Briefs
Weighing The Week Ahead: Investors Can Always Learn Something From Mr. Buffett
category Conglomerates , Capital & Industrial Goods , Services , and 3 more.
from Blogs - TalkMarkets
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
category LMAT , TECH , XBI , and 80 more.
from Benzinga
Stocks That Hit 52-Week Lows On Monday
category ESBK , NXRT , Human Resource & Employment Services , and 735 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.